Login | Register
AAPL AMZN CVX GOOGL KO NVDA MSFT META TSLA XOM
TMDIF - USD 0.04 (0.0043)
Titan Medical Inc.
52 week range 0.03 0.16
Exchange: PNK | Sector: Healthcare | Industry: Healthcare
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Summary stats | |
---|---|
Market cap. (USD) | 4,561,600 |
Beta | 1.98 |
Vol. avg. | 47,669.00 |
EPS | 0.06 |
P/E (TTM) | 0.53 |
Dividend yield (TTM) | 0.00% |
Dividend per share (TTM) | 0.00 |
Last dividend (USD) | 0.00 |
Score: C
Assessment: SPECULATIVE
Financial health | B+ |
Cash flow | B+ |
Growth | B |
Market performance | D |
Valuation | D |
Dividends | B |
USD (millions) | 2019 - FY | 2020 - FY | 2021 - FY | 2022 - FY | 2023 - FY |
---|---|---|---|---|---|
Total assets | 3 | 30 | 47 | 7 | 9 |
Total liabilities | 15 | 44 | 12 | 10 | 4 |
Total equity | -12 | -14 | 35 | -3 | 5 |
USD (millions) | 2019 - FY | 2020 - FY | 2021 - FY | 2022 - FY | 2023 - FY |
---|---|---|---|---|---|
Total revenues | 0 | 21 | 20 | 0 | 18 |
Total expenses | 61 | 17 | 51 | 43 | 8 |
Operating income | -61 | 4 | -31 | -43 | 10 |
Net income before tax | -43 | -25 | -15 | -41 | 7 |
Net income after tax | -43 | -25 | -15 | -41 | 7 |
USD (millions) | 2019 - FY | 2020 - FY | 2021 - FY | 2022 - FY | 2023 - FY |
---|---|---|---|---|---|
Cash flow from operating activities | -47 | -1 | -36 | -26 | 5 |
Cash flow from financing activities | 37 | 27 | 44 | 0 | 0 |
Cash flow from investing activities | 0 | -1 | -1 | -1 | 0 |
Net change in cash | -11 | 25 | 7 | -29 | 4 |
Free cash flow | -47 | -2 | -37 | -27 | 5 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gross profit margin How efficiently does the company convert revenue into gross profit? Higher is better | 0.00% | 100.00% | 100.00% | 0.00% | 98.95% |
Net profit margin How much net income does the company generate from revenue? Higher is better | 0.00% | -120.92% | -73.95% | 0.00% | 38.72% |
Return on Assets How effectively does the company use its assets to generate profit? Higher is better | -1,268.09% | -85.33% | -31.23% | -574.17% | 79.76% |
Return on Equity How well does the company generate returns on shareholders' equity? Higher is better | 367.08% | 184.38% | -41.79% | 1,291.87% | 146.06% |
Return on Invested Capital How efficiently is the company using its capital to generate profits? Higher is better | 519.48% | -33.84% | -84.98% | 2,333.52% | 183.11% |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Cash ratio Does the company have enough cash to cover short-term liabilities? Close to or greater than 1 is better | 0.05 | 0.59 | 2.97 | 0.37 | 2.42 |
Current ratio Can the company meet short-term obligations with current assets? Between 1.5 and 2 is better | 0.12 | 0.63 | 4.01 | 0.56 | 2.78 |
Quick ratio Can the company meet short-term liabilities without selling inventory? Above 1 is better | 0.12 | 0.63 | 4.01 | 0.58 | 2.78 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Debt ratio What proportion of the company's assets is financed by debt? Below 0.5 is better | 0.01 | 0.09 | 0.03 | 0.24 | 0.15 |
Debt to equity ratio How does the company's debt compare to its equity? Below 1 is better | 0.00 | -0.20 | 0.04 | -0.54 | 0.28 |
Interest coverage ratio Can the company cover its interest expenses comfortably? Above 3 is better | 0.00 | 4.05 | -166.02 | -290.52 | 46.66 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Asset growth Are the company's assets growing and how quickly? Higher is better. | -84.57% | 782.37% | 58.05% | -84.91% | 22.50% |
Book value per share growth Is the company increasing its net asset value, and how consistently? Higher is better. | -250.15% | 45.86% | 257.71% | -108.73% | 243.67% |
Debt growth Is the company's debt growing and how quickly? Lower is better. | 0.00% | 9,538.66% | -52.71% | 28.90% | -22.95% |
Earnings per share growth Is the company’s profitability growing, and at what rate? Higher is better. | -8.53% | 72.86% | 63.16% | -164.29% | 116.38% |
Revenue growth Is the company's revenue growing and how quickly? Higher is better. | 0.00% | 0.00% | -5.42% | -100.00% | 0.00% |
Net income growth Is the company's net income growing and how quickly? Higher is better. | -99.59% | 40.62% | 42.16% | -177.42% | 117.02% |
Free cash flow growth Is the company generating more free cash flow over time, and how steadily? Higher is better. | -19.69% | 96.80% | -2,335.78% | 25.86% | 116.57% |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Dividend yield What is the return from dividends relative to stock price? Higher is better for income-focused investors. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
P/E ratio How is the company's stock valued relative to its earnings? Lower is better, relative to industry averages. | -0.36 | -4.50 | -4.64 | -1.80 | 0.99 |
PEG ratio Is the stock fairly valued considering its growth? Closer to 1 is better. | -0.04 | 0.06 | 0.07 | -0.01 | -0.01 |
Price to free cash flow ratio How is the stock valued relative to its free cash flow? Lower is better. | -0.32 | -75.35 | -1.84 | -2.68 | 1.52 |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Dividend growth per share | 0% | 0% | 0% | 0% | 0% |
3 year dividend growth per share | 0% | 0% | 0% | 0% | 0% |
5 year dividend growth per share | 0% | 0% | 0% | 0% | 0% |
10 year dividend growth per share | 0% | 0% | 0% | 0% | 0% |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Dividend yield | 0% | 0% | 0% | 0% | 0% |
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Dividend payout ratio | 0% | 0% | 0% | 0% | 0% |
Free cash flow per share (USD) | -1.55 | -0.02 | -0.34 | -0.25 | 0.04 |
Valuation assessment (USD) | Discounted cash flow (USD) |
---|---|
0.00 |
No peers available.